L307-1825 Screening compound: N-[2-(azepan-1-yl)ethyl]-3-[4-(azepane-1-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide

L307-1825 Screening compound: N-[2-(azepan-1-yl)ethyl]-3-[4-(azepane-1-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide
L307-1825 Screening compound: N-[2-(azepan-1-yl)ethyl]-3-[4-(azepane-1-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L307-1825
N-[2-(azepan-1-yl)ethyl]-3-[4-(azepane-1-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L307-1825

Molecular Formula

C23H33N5O4S (C23 H33 N5 O4 S)

Compound Name

N-[2-(azepan-1-yl)ethyl]-3-[4-(azepane-1-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide

IUPAC name

N-[2-(azepan-1-yl)ethyl]-3-[4-(azepane-1-sulfonyl)phenyl]-124-oxadiazole-5-carboxamide

SMILES

O=C(c1nc(-c(cc2)ccc2S(N2CCCCCC2)(=O)=O)no1)NCCN1CCCCCC1

InChI

InChI=1S/C23H33N5O4S/c29-22(24-13-18-27-14-5-1-2-6-15-27)23-25-21(26-32-23)19-9-11-20(12-10-19)33(30,31)28-16-7-3-4-8-17-28/h9-12H,1-8,13-18H2,(H,24,29)

InChI Key

HOPGWSZYVLLKHW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243781

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.61

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.526

Distribution Coefficient, logD

1.928

Water Solubility, LogSw

-3.78

Polar Surface Area

92.526

Acid Dissociation Constant (pKa)

12.62

Base Dissociation Constant (pKb)

8.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

60.90

L307-1825 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L307-1825 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L307-1825?
Check Price and Availability of L307-1825, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L307-1825 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L307-1825
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L307-1825
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L307-1825 available by request